Back

The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 2 Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ven Gee Lim

University Hospitals of Coventry and Warwickshire NHS Trust, Coventry (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.
Ms C. van der Heijden (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.
Miss L. Aerts (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial
Doctor I. Prepolec (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial
Doctor I. Romanazzi (Bari, IT)
Abstract Slides Video
Presentation thumbnail
Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial
Doctor M. Wijffels (Nieuwegein, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 2

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial
thumbnail
Congress Presentation
Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.
thumbnail
Congress Presentation
Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources